Cande, Nenita L.

HRN: 00-81-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
CEFTRIAXONE 1G (VIAL)
05/11/2023
05/18/2023
IV
2g
Q12 Hours
CAP-MR; Presumptive PTB; T/c TB Meningitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: